<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>风云药谈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-10-29T20:22:11+08:00</updated>
  <subtitle>分享、交流、学习</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>“五省联盟”17大品种新玩法“凡带量、必轮选”</title>
    <updated>2020-10-29T19:18:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/0YtQKlI1UsK-VyjO7gD-eA</id>
    <link href="https://mp.weixin.qq.com/s/0YtQKlI1UsK-VyjO7gD-eA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>外企将全面落地“药代备案”，内资企业何去何从？</title>
    <updated>2020-10-28T19:25:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/55Pz88zwnJwmwaOsiaTNug</id>
    <link href="https://mp.weixin.qq.com/s/55Pz88zwnJwmwaOsiaTNug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采第二批半年完成160%，中选使用85%，NB</title>
    <updated>2020-10-27T18:04:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-27:/s/imV00zz1E6Xi9enlP10RfQ</id>
    <link href="https://mp.weixin.qq.com/s/imV00zz1E6Xi9enlP10RfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>湖南“市级带量采”新规必须重视起来</title>
    <updated>2020-10-26T18:00:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/1xRWyvQZOn0h3poPcgQ7-A</id>
    <link href="https://mp.weixin.qq.com/s/1xRWyvQZOn0h3poPcgQ7-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“最强乙肝药TAF”国产上市，还能嗨到“两亿保证金”？</title>
    <updated>2020-10-20T19:11:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-20:/s/L-DOxMFAIK78taT3_hfD0Q</id>
    <link href="https://mp.weixin.qq.com/s/L-DOxMFAIK78taT3_hfD0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅：DRG要全国推进执行？</title>
    <updated>2020-10-19T16:05:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/rHgBm_sgqTLWmhIZU-nsVg</id>
    <link href="https://mp.weixin.qq.com/s/rHgBm_sgqTLWmhIZU-nsVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家医疗保障局办公室关于印发区域点数法总额预算和按病种分值付费试点工作方案的通知</title>
    <updated>2020-10-19T16:05:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-19:/s/nW7grbgwJj1S7qBnHDCEaQ</id>
    <link href="https://mp.weixin.qq.com/s/nW7grbgwJj1S7qBnHDCEaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>钟南山发声板蓝根，药企新玩法？秀秀秀！</title>
    <updated>2020-10-18T19:02:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-18:/s/A-_WHTcVy1AcQoAEJPz4_w</id>
    <link href="https://mp.weixin.qq.com/s/A-_WHTcVy1AcQoAEJPz4_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>五个老铁撸串聊“医药代表备案”，“喝多”打起来了！</title>
    <updated>2020-10-15T20:42:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-15:/s/cD7pPBJMNnnsQhIz0cMCcQ</id>
    <link href="https://mp.weixin.qq.com/s/cD7pPBJMNnnsQhIz0cMCcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>反原料药垄断“新文件”，老药新做到头了？</title>
    <updated>2020-10-14T16:24:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-14:/s/uxhYCkIrn9Jut7DJN1u8lQ</id>
    <link href="https://mp.weixin.qq.com/s/uxhYCkIrn9Jut7DJN1u8lQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>麻醉“一哥-丙泊酚”，首过评满三家！</title>
    <updated>2020-10-12T18:24:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-12:/s/FpN6EH_eoIrWQmcxV-Mx6g</id>
    <link href="https://mp.weixin.qq.com/s/FpN6EH_eoIrWQmcxV-Mx6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>